Biotechnology
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company made that clear on Wednesday, announcing positive clinical trial data on three experimental vaccines for other diseases. The company is moving those shots to final stage studies, it said. The update brings Moderna a step closer […]
Read More
Fda approves Merck's drug for exceptional, deadly lung ailment
The Foods and Drug Administration on Tuesday accredited a drug from Merck created to handle a progressive and existence-threatening lung situation in a earn for each the drugmaker and for patients suffering from the uncommon illness. The company greenlighted the therapy, which will be marketed as Winrevair, for older people with pulmonary arterial hypertension. The […]
Read More
Moderna says new Covid vaccine showed stronger immune response than current shot in study
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot in a late-stage trial. The results come as Moderna competes with rival Pfizer for more share […]
Read More
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data
Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares jumped more than 15% on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker’s prospects in […]
Read More
Nvidia's AI ambitions in medicine and health care are becoming clear
Nvidia CEO Jensen Huang delivers a keynote address during the Nvidia GTC Conference at the SAP Center in San Jose, California, on March 18, 2024. Justin Sullivan | Getty Images Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health […]
Read More
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable […]
Read More
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts. But some patients are willing to pay more out of […]
Read More
Medicare can now cover certain weight loss drugs in a big step for patients
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Medicare can start covering certain weight loss drugs for the first time – as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. […]
Read More
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of […]
Read More
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of […]
Read More